Webinare & E-Learning Kurse Alle Webinare

Human Medical Toxicity for GP Nurses

Human Medical Toxicity for GP Nurses
Human Medical Toxicity for GP Nurses

Referent:In

Najda.jpg

Nadja Sigrist

PD, DVM, Small animal specialist FVH, DACVECC, DECVECC, EBVS specialist in veterinary emergency and critical care

After graduating from the veterinary school of the university of Bern in 1996, Nadja completed a doctoral thesis and trained as a specialist for small animals (FVH) before completing a residency in Veterinary Emergency and Critical Care. She is an ACVECC Diplomate since 2004 and ECVECC founding Diplomate since 2014. 
From 2005-2010 she was senior clinician in ECC medicine and helped developed the emergency and ICU service at the Small Animal Hospital of the Vetsuisse Faculty of Bern and from 2013-2020 she was senior clinician and the head of the Small Animal Intensive Care Unit at the Small Animal Hospital of the Vetsuisse Faculty of Zürich. 
In 2021, Nadja left the university setting to concentrate on her own company VET ECC CE (Veterinary Emergency and Critical Care Consulting & Education).

Buchungsinfo

Dauer: 1:01 h
Referent:In Nadja Sigrist
ab 1
57,60 US$
(inkl. USt.)

Das könnte Sie auch interessieren

E_2026_02_19_Immune-mediated Polyarthritis - When to suspect, what to rule out and what to treat with_300x200-2.png
Craig Breheny
1:00 h

Immune-mediated polyarthritis - when to suspect, what to rule out and what to treat with

Immune-mediated polyarthritis can affect many body systems and prove a diagnostic challenge. With abundant underlying triggers, Craig Breheny will talk about how deciding on a work up plan, and the associated therapeutic interventions can be a challenge.
28.01.26 Image 300x200.jpg
Marisa Lourenco
1:15 h

Interpreting electrolytes and acid-base in the ER

Diagnosis and management of the most common electrolyte and acid-base disturbances presented in the emergency setting with Marisa Lourenco

 


Image temp 30.07 (1).png
Thierry Beths
0:45 h

Total Intravenous Anaesthesia - Where are we

Thierry Beths shares the latest in pharmacokinetics and in technology that allows us to provide TIVA in a more controlled way, targeting specific drug concentrations, resulting in more stable anaesthesia.